VAXART INC Cash Flow - Quarterly (NASDAQ:VXRT)

Add to My Stocks
$2.54 $0.13 (4.87%) VXRT stock closing price Sep 18, 2018 (Closing)
View Previous Quarters
View Next Quarters
Fiscal year is Jan - Dec2018 Q22018 Q12017 Q42017 Q32017 Q22017 Q12016 Q42016 Q32016 Q22016 Q1
Net Income Cash Flow
Depreciation Depletion Amortization Cash-Flow1.46M---------
Net Increase (Decrease) in Assets Liabilities5.34M-7.15M---1.2M-7.5M-0.1M-1.5M9.1M1.6M
Cash From (used in) Discontinued Operations----------
Other Adjustments Net-3.72M-6.27M-1.1M---0.2M-0.5M-2.1M1.6M
Net Cash from (used by) Operating Activities
Increase (Decrease) in Prop Plant And Equipment-0.34M-0.14M-------0.2M-0.1M
Acquisition Disposition of Subsidiaires25.5M25.5M--------
Increase (Decrease) in Investments1.42M1.41M20.9M6.4M-1.59M-6.49M8.2M6.9M1.5M1.4M
Other Cash Inflow (Outflow) from Investment Activities----------
Net Cash from (used by) Investment Activities
Issuance (Purchase) of Equity Shares----------
Issuance (Repayment) of Debt Securities-0.69M-0.27M---0.4M-0.2M-0.1M--0.3M-0.2M
Increase (Decrease) in Bank & Other Borrowings-0.06M---------
Payment of Dividends & Other Cash Distributions----------
Other Cash from (used by) Financing Activities--------18.1M-
Net Cash from (used by) Financing Activities
Effect of Exchange Rate Changes on Cash----------
Net Change in Cash & Cash Equivalents
Cash & Equivalents at Beginning of Year1.57M49.7M44.7M81.7M66.8M53.8M94.31M53.56M59.51M106.43M
Cash & Equivalents at Year End23.92M17.49M29.4M19.6M17.7M11.8M38.1M45.9M49.7M30.6M
All figures in USD. M: Millions of USD, B: Billions of USD.
View Previous Quarters
View Next Quarters

Click here to view our BioCryst Pharma financial analysis

Key Financial Ratios For VAXART INC Cash Flow

FCF margin